Amid listeria outbreak, U.S. company pulls food from shelves
NEW YORK, May 12 (Xinhua) -- A Southland food company has yanked several of its premade food offerings from businesses across California and three other U.S. states after federal regulators found a strain of listeria on its equipment linked to an outbreak first identified last year that has sickened at least 10 people.
Fresh & Ready Foods, based in San Fernando, voluntarily recalled several of its premade sandwiches and protein snacks, including several varieties of ham and turkey sandwiches, egg salad sandwiches, tuna pasta, and a street corn dipper snack. The items were sold under three brands: Fresh & Ready Foods, City Point Market Fresh Food to Go, and Fresh Take Crave Away.
"The voluntarily recalled food was distributed between April 18 and 28 this year in California, Nevada, Arizona and Washington. It was to be sold in vending machines and other settings in hospitals, hotels, convenience stores and airports, and by airlines. The recalled items have 'Use by' dates from April 22 through May 19," reported the Los Angeles Times on Sunday about the development.
The recall was prompted by a routine inspection this April at a Fresh & Ready facility where investigators found a strain of listeria monocytogenes on a piece of equipment, according to news releases by the company and federal officials. Fresh & Ready workers then removed the equipment and took other actions to remedy the issue, the company said in a statement.
The symptoms of a listeria infection include fever, muscle aches, fatigue, headache, stiff neck, confusion, loss of balance, and even seizures. It can also include intestinal issues such as diarrhea and vomiting.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
an hour ago
- The Star
New York moves to allow terminally ill people to die on their own terms
NEW YORK, June 10 (Xinhua) -- The New York State Senate approved a bill on Monday that would allow people facing terminal diagnoses to end their lives on their own terms, which the bill's proponents say would grant a measure of autonomy to New Yorkers in their final days. The bill, which passed the State Assembly earlier this year, will now head to the desk of Governor Kathy Hochul, a Democrat, for her signature. "It is unclear whether she plans to sign it; a spokesman for her office said she would review it," reported The New York Times. Eleven states and the District of Columbia have passed laws permitting so-called medical aid in dying. The practice is also available in several European countries and in Canada, which recently broadened its criteria to extend the option to people with incurable chronic illnesses and disabilities. According to the report, the bill in New York is written more narrowly and would apply only to people who have an incurable and irreversible illness, with six months or less to live. Proponents say that distinction is key.
The Star
an hour ago
- The Star
COVID-19 virus protein triggers immune attack on healthy cells: study
JERUSALEM, June 10 (Xinhua) -- Israeli researchers have discovered that a protein from the SARS-CoV-2 virus, responsible for COVID-19, can cause the immune system to attack healthy cells mistakenly, the Hebrew University of Jerusalem said in a statement on Tuesday. The study, published in Cell Reports, sheds light on how severe COVID-19 complications may occur and suggests new ways to prevent immune-driven damage from the virus. The researchers found that the virus's nucleocapsid protein (NP), which normally helps package the virus's genetic material inside infected cells, can spread to nearby uninfected epithelial cells. Once on the surface of these healthy cells, NP would be mistakenly identified by the immune system as a threat. The immune system then deploys anti-NP antibodies, which mark these uninfected cells for destruction. The process triggers the classical complement pathway, a part of the immune response that leads to inflammation and tissue damage, contributing to severe COVID-19 symptoms and possibly long COVID. Using lab-grown cells, advanced imaging, and samples from COVID-19 patients, the researchers found that NP binds to a type of molecule on cell surfaces. The binding causes the protein to cluster on healthy cells, further confusing the immune system. The study also found that the drug enoxaparin, a common blood thinner and heparin analog, blocks NP from sticking to healthy cells. In both lab tests and patient samples, enoxaparin helped prevent immune attacks by occupying the binding sites that NP uses. According to the researchers, the discovery may offer new hope for reducing immune-related complications in COVID-19 and potentially other viral infections.
The Star
2 days ago
- The Star
Sri Lanka issues new guidelines to curb dengue, Chikungunya in schools
COLOMBO: Sri Lanka's Ministry of Education has issued instructions to prevent the spread of dengue and Chikungunya in schools across the country, local media reported on Sunday (June 8). According to the new instructions, school principals could face legal action if mosquito breeding sites are found on school premises during inspections. The ministry said that each school must develop and implement its programme to eliminate mosquito breeding sites while continuing educational activities without disruption. The ministry has sent notices to principals of all public and government-approved private schools, heads of religious schools, deans of national colleges of education, and heads of other educational institutions and provincial offices to inform them about the new measures. The ministry said there would be periodic inspections of schools. Dengue and Chikungunya cases are on the rise in Sri Lanka. - Xinhua
